News

Venture Challenge Alumnus of 2010 NTRC Therapeutics closes deal with Symeres and sells CRO division Oncolines B.V

  Oncolines B.V., the CRO division of NTRC B.V. has been acquired by Symeres. NTRC Therapeutics participated in the Venture Challenge of 2010. The team consisted of Guido Zaman and Rogier Buijsman.
Venture Challenge Alumnus of 2010 NTRC Therapeutics closes deal with Symeres and sells CRO division Oncolines B.V

Venture Challenge Alumnus Autosciber closes 1,2 Million Euro Seed round

Venture Challenge Alumnus Autoscriber, an AI-based voice recognition software that captures and summarises consultations between healthcare professionals and patients, has closed its Seed round at €1.2M.
photo of founders

Protinhi Therapeutics successful in EIC Accelerator

Venture Challenge alumnus Prothinhi Therapeutics was one of the 11 Dutch companies that were successful in the latest IEC Accelerator round, together they raised €77mln.
EIC Accelerator

Expert Class on reimbursement very insightful

At the final expert class of 2022 we were happy to welcome a large group of startups that were keen to learn all about reimbursement.
Expert Class

Venture Challenge wins prestigious European Award

The lifesciences@work Venture Challenge has won the European Enterprise Promotion Award 2022 (EEPA) in the category ‘Improving the Business Environment and Supporting the Digital Transition’. We - Chrétien Herben and Simone Hermans - were invited to the EEPA finals in Prague after winning the National EEPA round in June of this year. 
Venture Challenge wins prestigious European Award

PrecorDx Wins the Venture Challenge Fall 2022!

The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2022 fall edition is PrecorDx! The innovative startup PrecorDx has developed a non-invasive diagnostic platform aimed at reducing hospitalization & slowing disease progression in heart failure.
© Nils van Houts Fotografie

Amsterdam UMC spin-off PacingCure received EIC Transition funding

Amsterdam UMC spin-off PacingCure received a prestigious EIC Transition grant of 2.5 million euros. PacingCure develops platform gene transfer technologies for the heart and uses these technologies to engin
Amsterdam UMC spin-off PacingCure received EIC Transition funding

Review of the MedtechMeeting Q4!

Yesterday Roessingh Research and Development (RRD) hosted the final Medtech Meeting of this year.
impression

Venture Challenge bootcamp 2!

  Last week the second three-day bootcamp of the Venture Challenge fall 2022 edition took place in Villa Vennendal.
our test jury

The lifesciences@work Venture Challenge Spring 2023 call opens soon

  Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other res
group photo of winners previous VC